FTRE — Fortrea Holdings Inc.
—
Nasdaq ·
Health Care ·
Health Care Providers & Services ·
CIK 1965040 ·
Last close
$19.89
Market Cap
$1.89B
52W High
$21.39
52W Low
$8.31
ADV30
1,339,380
Next earnings
2026-11-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | — | — | — |
| Mar 2026 | 636,500,000 | 123,600,000 | 3,300,000 | -23,600,000 | 2,683,400,000 | 147,500,000 | 2,157,500,000 |
| Dec 2025 | 660,500,000 | 131,100,000 | 8,800,000 | -32,500,000 | 2,715,700,000 | 174,600,000 | 2,152,200,000 |
| Sep 2025 | 701,300,000 | 122,700,000 | -3,700,000 | -15,900,000 | 2,742,100,000 | 131,300,000 | 2,161,300,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$227,800,000
Investing CF
$-9,200,000
Financing CF
$-125,700,000
CapEx
$-31,800,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.91
As of
2026-08-02
Balance + Analyst (yfinance extras)
Retained Earnings
$-1,420,000,000
Inventory
—
Receivables
$654,400,000
ST Investments
—
EBIT TTM
$6,400,000
Pretax Income TTM
$-77,800,000
Interest Exp TTM
$84,200,000
Analysts
11
Yahoo Snapshot (yfinance, live)
Total Revenue
$2,676,499,968
EBITDA
$98,300,000
Free Cash Flow
$278,862,496
Enterprise Value
$2,584,920,064
Total Cash
$168,600,000
Total Debt
$1,117,799,936
Shares Out
95,100,000
Trailing EPS
$-0.83
Book Value
$5.51
ROE
-15.3%
ROA
0.6%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 2,723,400,000 | -30,600,000 | -986,200,000 | 2,715,700,000 | 2,152,200,000 | 563,500,000 | 113,500,000 |
| Dec 2024 | 2,696,400,000 | -111,800,000 | -328,500,000 | 3,579,200,000 | 2,216,800,000 | 1,362,400,000 | 262,800,000 |
| Dec 2023 | 2,842,500,000 | 53,200,000 | -25,200,000 | 4,332,600,000 | 2,618,500,000 | 1,714,100,000 | 168,400,000 |
| Dec 2022 | 2,837,000,000 | 222,800,000 | 186,200,000 | 4,287,900,000 | 945,300,000 | 3,342,600,000 | 82,700,000 |
TTM Snapshot
Revenues TTM
$2,138,500,000
NetIncome TTM
$-91,800,000
OpCashFlow TTM
$0
Assets (Latest)
$3,579,200,000
Forward EPS
$1.14
Max Pain — expiry 2026-11-20
max pain strike: $15.00 · spot: $20.12 · call oi: 6,308 · put oi: 30Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| SGRY | Surgery Partners, Inc. | $1.89B | $14.40 | — |
| PGNY | Progyny, Inc. | $1.95B | $25.44 | — |
| SNDA | SONIDA SENIOR LIVING, INC. | $1.81B | $37.71 | — |
| PSNL | Personalis, Inc. | $1.76B | $16.46 | — |
| ADUS | Addus HomeCare Corp | $2.11B | $113.19 | — |
News headlines (Yahoo Finance, 1h cache)
Fortrea (FTRE) Stock Could Be 46% Undervalued As Deal Questions Build
2026-09-27 00:12 · Yahoo
2 Small-Cap Stocks to Research Further and 1 Facing Challenges
2026-09-23 08:37 · Yahoo
CRO consolidation keeps rolling. What does that mean for pharma?
2026-09-22 13:00 · Yahoo
2 of Wall Street’s Favorite Stocks to Target This Week and 1 Facing Challenges
2026-09-16 07:08 · Yahoo
Fortrea to Participate in September Investor Conferences
2026-09-10 12:58 · Yahoo
Stocks making big moves this week: SAIC, Reddit, Fortrea, GitLab, and G-III
2026-09-04 20:38 · Yahoo
Fortrea (FTRE) Stock Is Up, What You Need To Know
2026-09-03 03:00 · Yahoo
Fortrea to Acquire Clinical Pharmacology Unit and Bioanalytical Laboratory Operations from Worldwide Clinical Trials
2026-09-02 11:00 · Yahoo
Drug Development Inputs & Services Stocks Q2 In Review: Fortrea (NASDAQ:FTRE) Vs Peers
2026-08-15 00:37 · Yahoo
Fortrea (FTRE) Gains Traction in Turnaround
2026-08-11 12:24 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.